Want to see BBNX full AI Analyst Report?

Beta Bionics, Inc. (BBNX) Stock Forecast & Price Target

65 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

BBNX Analyst Ratings

Strong Buy

7 Buy

1 Hold

0 Sell

Based on 8 analysts giving stock ratings to

Beta

Bionics, Inc.

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

BBNX Stock 12 Month Forecast

Average Price Target

$21.11

▲(33.20% Upside)

Based on 8 Wall Street analysts offering 12 month price targets for Beta Bionics, Inc. in the last 3 months. The average price target is $21.11 with a high forecast of $30.40 and a low forecast of $15.50. The average price target represents a 33.20% change from the last price of $15.85.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"9":"$9","20":"$20","31":"$31","14.5":"$14.5","25.5":"$25.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":30.4,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$30.40</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":21.1125,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$21.11</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$15.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[9,14.5,20,25.5,31],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.83,14.181538461538462,15.533076923076923,16.884615384615387,18.236153846153847,19.587692307692308,20.939230769230768,22.29076923076923,23.642307692307693,24.993846153846157,26.345384615384617,27.696923076923078,29.048461538461538,{"y":30.4,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.83,13.467115384615385,14.10423076923077,14.741346153846154,15.378461538461538,16.015576923076924,16.65269230769231,17.289807692307694,17.926923076923078,18.564038461538463,19.201153846153847,19.83826923076923,20.475384615384616,{"y":21.1125,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.83,13.035384615384615,13.240769230769232,13.446153846153846,13.651538461538461,13.856923076923078,14.062307692307693,14.267692307692307,14.473076923076924,14.678461538461539,14.883846153846154,15.08923076923077,15.294615384615385,{"y":15.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":16.4,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.02,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.21,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.22,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.53,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.47,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.7,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.52,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.01,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.29,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.8,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.7,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.83,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$30.40

Average Price Target$21.11

Lowest Price Target$15.50

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Richard Newitter

Truist Financial

$22

Buy

38.80%

Upside

Reiterated

07/30/26

Analysts Offer Insights on NA Companies: Waystar Holding Corp. (NASDAQ: WAY) and Beta Bionics, Inc. (NASDAQ: BBNX)

Jonathan Block

Stifel Nicolaus

$20

Buy

26.18%

Upside

Reiterated

07/30/26

Analysts Are Bullish on Top NA Stocks: Waystar Holding Corp. (WAY), Beta Bionics, Inc. (BBNX)

Travis Steed

Bank of America Securities

$13→$15.5

Hold

-2.21%

Downside

Reiterated

07/30/26

Beta Bionics price target raised to $15.50 from $13 at BofABeta Bionics price target raised to $15.50 from $13 at BofA

Jeffrey Cohen

Ladenburg Thalmann & Co.

$30.4

Buy

91.80%

Upside

Reiterated

07/30/26

Analysts Offer Insights on NA Companies: Beta Bionics, Inc. (NASDAQ: BBNX) and Waystar Holding Corp. (NASDAQ: WAY)

Frank Takkinen

Lake Street

$20

Buy

26.18%

Upside

Reiterated

07/30/26

Lake Street Sticks to Its Buy Rating for Beta Bionics, Inc. (BBNX)

Matthew O'Brien

Piper Sandler

$20

Buy

26.18%

Upside

Reiterated

07/30/26

Piper Sandler Reaffirms Their Buy Rating on Beta Bionics, Inc. (BBNX)

Danielle Antalffy

UBS

$22

Buy

38.80%

Upside

Initiated

07/28/26

Beta Bionics resumed with a Buy at UBSBeta Bionics resumed with a Buy at UBS

David Roman

Goldman Sachs

$17→$19

Buy

19.87%

Upside

Assigned

07/15/26

Beta Bionics price target raised to $19 from $17 at Goldman SachsBeta Bionics price target raised to $19 from $17 at Goldman Sachs

Mathew Blackman

TD Cowen

$16

Hold

0.95%

Upside

Reiterated

04/21/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Beta Bionics, Inc. (NASDAQ: BBNX) and Danaher (NYSE: DHR)

Jeff Johnson

Robert W. Baird

$28→$14

Hold

-11.67%

Downside

Reiterated

02/18/26

Beta Bionics price target lowered to $14 from $28 at BairdBeta Bionics price target lowered to $14 from $28 at Baird

Mike Kratky

Leerink Partners

$28

Buy

76.66%

Upside

Reiterated

09/12/25

Leerink Partners Sticks to Their Buy Rating for Beta Bionics, Inc. (BBNX)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Richard Newitter

Truist Financial

$22

Buy

38.80%

Upside

Reiterated

07/30/26

Analysts Offer Insights on NA Companies: Waystar Holding Corp. (NASDAQ: WAY) and Beta Bionics, Inc. (NASDAQ: BBNX)

Jonathan Block

Stifel Nicolaus

$20

Buy

26.18%

Upside

Reiterated

07/30/26

Analysts Are Bullish on Top NA Stocks: Waystar Holding Corp. (WAY), Beta Bionics, Inc. (BBNX)

Travis Steed

Bank of America Securities

$13→$15.5

Hold

-2.21%

Downside

Reiterated

07/30/26

Beta Bionics price target raised to $15.50 from $13 at BofABeta Bionics price target raised to $15.50 from $13 at BofA

Jeffrey Cohen

Ladenburg Thalmann & Co.

$30.4

Buy

91.80%

Upside

Reiterated

07/30/26

Analysts Offer Insights on NA Companies: Beta Bionics, Inc. (NASDAQ: BBNX) and Waystar Holding Corp. (NASDAQ: WAY)

Frank Takkinen

Lake Street

$20

Buy

26.18%

Upside

Reiterated

07/30/26

Lake Street Sticks to Its Buy Rating for Beta Bionics, Inc. (BBNX)

Matthew O'Brien

Piper Sandler

$20

Buy

26.18%

Upside

Reiterated

07/30/26

Piper Sandler Reaffirms Their Buy Rating on Beta Bionics, Inc. (BBNX)

Danielle Antalffy

UBS

$22

Buy

38.80%

Upside

Initiated

07/28/26

Beta Bionics resumed with a Buy at UBSBeta Bionics resumed with a Buy at UBS

David Roman

Goldman Sachs

$17→$19

Buy

19.87%

Upside

Assigned

07/15/26

Beta Bionics price target raised to $19 from $17 at Goldman SachsBeta Bionics price target raised to $19 from $17 at Goldman Sachs

Mathew Blackman

TD Cowen

$16

Hold

0.95%

Upside

Reiterated

04/21/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Beta Bionics, Inc. (NASDAQ: BBNX) and Danaher (NYSE: DHR)

Jeff Johnson

Robert W. Baird

$28→$14

Hold

-11.67%

Downside

Reiterated

02/18/26

Beta Bionics price target lowered to $14 from $28 at BairdBeta Bionics price target lowered to $14 from $28 at Baird

Mike Kratky

Leerink Partners

$28

Buy

76.66%

Upside

Reiterated

09/12/25

Leerink Partners Sticks to Their Buy Rating for Beta Bionics, Inc. (BBNX)

Stocks with the Highest Top Analyst Consensus in the General Sector

ITGITG Inc. Class A

LIMENeutron Holdings, Inc.

EROCERock

CBRSCerebras Systems, Inc. Class A

FRVOFervo Energy Company Class A

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Beta Bionics, Inc.

3 Months

Frank TakkinenLake Street

Success Rate

6/11 ratings generated profit

Average Return

+11.06%

Copying Frank Takkinen's trades and holding each position for 3 Months would result in 54.55% of your transactions generating a profit, with an average return of +11.06% per trade.

1 Year

Matthew O'BrienPiper Sandler

Success Rate

4/10 ratings generated profit

Average Return

-12.78%

Copying Matthew O'Brien's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of -12.78% per trade.

2 Years

Matthew O'BrienPiper Sandler

Success Rate

4/10 ratings generated profit

Average Return

-7.53%

Copying Matthew O'Brien's trades and holding each position for 2 Years would result in 40.00% of your transactions generating a profit, with an average return of -7.53% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BBNX Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, BBNX has received 10 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. BBNX average Analyst price target in the past 3 months is 21.11.

Each month's total comprises the sum of three months' worth of ratings.

BBNX Financial Forecast

BBNX Earnings Forecast

Next quarter’s earnings estimate for BBNX is -$0.55 with a range of -$0.61 to -$0.51. The previous quarter’s EPS was -$0.53. BBNX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 66.67% of the time in the same period. In the last calendar year BBNX has Performed in-line its overall industry.

BBNX Sales Forecast

Next quarter’s sales forecast for BBNX is $35.01M with a range of $33.98M to $35.58M. The previous quarter’s sales results were $32.01M. BBNX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 83.33% of the time in the same period. In the last calendar year BBNX has Performed in-line its overall industry.

BBNX Stock Forecast FAQ

What is BBNX’s average 12-month price target, according to analysts?

Based on analyst ratings, Beta Bionics, Inc.’s 12-month average price target is 21.11.

What is BBNX’s upside potential, based on the analysts’ average price target?

Beta Bionics, Inc. has 33.20% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is BBNX a Buy, Sell or Hold?

Beta Bionics, Inc. has a consensus rating of Strong Buy which is based on 7 buy ratings, 1 hold ratings and 0 sell ratings.

What is Beta Bionics, Inc.’s price target?

The average price target for Beta Bionics, Inc. is 21.11. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $30.40 ,the lowest forecast is $15.50. The average price target represents 33.20% Increase from the current price of $15.85.

What do analysts say about Beta Bionics, Inc.?

Beta Bionics, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.

How can I buy shares of BBNX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Beta Bionics, Inc. (BBNX) Stock Forecast & Price Target

BBNX Analyst Ratings

BBNX Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Beta Bionics, Inc.

BBNX Analyst Recommendation Trends

BBNX Financial Forecast

BBNX Earnings Forecast

BBNX Sales Forecast

BBNX Stock Forecast FAQ

Detailed List of Analyst Forecasts